Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,... – Binds expression product or fragment thereof of...
Patent
1994-07-07
1997-02-11
Jones, W. Gary
Drug, bio-affecting and body treating compositions
Immunoglobulin, antiserum, antibody, or antibody fragment,...
Binds expression product or fragment thereof of...
435 6, 435 912, 536 231, 536 243, A61K 39395, C12Q 168, C12P 1934, C07H 2102
Patent
active
056018207
ABSTRACT:
The amino acid sequence of the full length version of the human neurotrophic factor receptor TRK B and a nucleotide sequence encoding it are disclosed. Transformed host cells and transgenic animals containing nucleic acid molecules encoding full length human TRK-B are disclosed. Probes, primers and antisense molecules identical and complementary to the nucleotide sequence that encodes full length human TRK-B, particularly the intracellular portion of the receptor are disclosed. Monoclonal antibodies that bind to the full length human TRK-B protein are disclosed. Methods of using and kits which include probes, primers, antisense molecules and monoclonal antibodies are disclosed.
REFERENCES:
patent: 4736866 (1988-04-01), Leder
patent: 4873191 (1989-10-01), Wagner
patent: 5231001 (1993-07-01), Kaplan et al.
Allan et al. Neuroscience 60: 825-834 1994.
Middlemass, Molecular and Cellular Biology 11: 143-153 1991.
Ausubel et al, In a Compendium of Methods from Current Protocols in Molecular Biology, Harvard Med. School, MA pp. 15-13 to 15-20 1993.
Innis and Gelfand, in PCR Protocols, Academic Press, San Diego, CA., pp. 15-16 1990.
Manak and Keller, in DNA Probes, MacMillan Publishers, N.Y. 1993.
Ehrhard, P. et al., "Expression of Low-affinity NGF Receptor and trkB mRNA in Human SH-SY5Y Neuroblastoma Cells", FEBS 1993, 330(3), 287-292.
Merlio, J.-P. et al., "Increased Production of the TrkB Protein Tyrosine Kinase Receptor after Brain Insults", Neuron 1993, 10, 151-164.
Nakagawara, A. et al., "Expression and Function of TRK-B and BDNF in Human Neuroblastomas", Molecular and Cellular Biology 1994, 14(1), 759-767.
Klein et al., "The trkB Tyrosine Protein Kinase Gene Codes for a Second Neurogenic Receptor that Lacks the Ctalytic Kinase Domain", Cell 61: 647-656 (1990).
Klein et al., "trkB, a Novel Tyrosine Protein Kinase Receptor Expressed During Mouse Neural Development", EMBO Journal 8: 3701-3709 (1989).
Loose-Mitchell, "Antisense Nucleic Acids as a Potential Class of Pharmaceutical Agents", TIPS 9: 45-47 (1988).
Marcus-Sekura, "Techniques for Using Antisense Oligodeoxyribonucleotides to Study Gene Expression", Anal. Biochemistry 172: 289-295 (1988).
Middlemas et al., "trkB, a Neural Receptor Protein-Tyrosine Kinase: Evidence for a Full-Length and Two Truncated Receptors", Molecular and Cellular Biology 11: 143-153 (1991).
Snider, W. D., "Functions of the Neurotrophins During Nervous System Development: What the Knockouts are Teaching Us", Cell 77: 627-638 (1994).
Stein, C. A. & J. S. Cohen, "Oligodeoxynucleotides as Inhibitors of Gene Expression: A Review", Cancer Research 48: 2659-2668 (1988).
Van der Krol, J. N. Mol, & A. R. Stuitje, "Modulation of Eukaryotic Gene Expression by Complementary RNA or DNA Sequences", BioTechniques 6: 958-973 (1988).
Walder, J., "Antisense DNA and RNA: Progress and Prospects", Genes & Development 2: 502-504 (1988).
Zon, "Oligonucleotide Analogues as Potential Chemotherapeutic Agents", Pharmaceutical Research 5: 539-549 (1988).
Zon, "Synthesis of Backbone-Modified DNA Analogues for Biological Applications", Journal of Protein Chemistry 6:131-145 (1987).
Brodeur Garrett M.
Nakagawara Akira
Children's Hospital of Philadelphia
Jones W. Gary
Rees Dianne
LandOfFree
Compositions and methods of making and using human full length T does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Compositions and methods of making and using human full length T, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compositions and methods of making and using human full length T will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-339728